{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:58:02Z","timestamp":1793739482085,"version":"4.6.1"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Prostate cancer (PCa) remains a leading cause of cancer-related mortality in men worldwide, primarily due to its propensity for therapy resistance and metastasis. Emerging evidence underscores that exosomes, nanoscale extracellular vesicles, act as critical mediators of intercellular communication within the tumor microenvironment (TME), particularly via the non-coding RNAs (ncRNAs) they transport. These molecules include microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs). Exosomal ncRNAs drive tumor progression, immune evasion, and therapy resistance by reprogramming neighboring stromal cells, immune cells, and malignant cells. This review systematically examines the multifaceted roles of exosomal ncRNAs in remodeling the prostate cancer tumor microenvironment, focusing on their communication between tumor cells, tumor-stromal cells (including immune cells), and within the pre-metastatic niche preceding bone metastasis. We emphasize their mechanisms of action and clinical relevance. These findings position exosomal ncRNAs as central drivers of prostate cancer progression, revealing novel diagnostic and therapeutic opportunities. Future research must address challenges in standardizing exosome isolation techniques, resolving spatiotemporal heterogeneity, and advancing clinical translation to fully realize the potential of exosome-based strategies in precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1644861","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:30:11Z","timestamp":1763706611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Exosomal non-coding RNAs: orchestrators of intercellular crosstalk in the prostate cancer tumor microenvironment"],"prefix":"10.3389","volume":"16","author":[{"given":"Huanglin","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baisheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48252","article-title":"An in-depth look into the epidemiological and etiological aspects of prostate cancer: A literature review","volume":"15","author":"Al-Ghazawi","year":"2023","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/pros.24258","article-title":"Spatial and temporal patterns of prostate cancer burden and their association with Socio-Demographic Index in Asia, 1990-2019","volume":"82","author":"Luo","year":"2022","journal-title":"Prostate"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1186\/s12889-023-17440-7","article-title":"Significantly reduced incidence and improved survival from prostate cancer over 25 years","volume":"23","author":"Serd\u00e0-Ferrer","year":"2023","journal-title":"BMC Public Health"},{"key":"B4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpet.2024.03.011","article-title":"Prostate cancer radioligand therapy: beta-labeled radiopharmaceuticals","volume":"19","author":"Yechiel","year":"2024","journal-title":"PET Clin"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.12701\/jyms.2023.00234","article-title":"Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study","volume":"40","author":"Kim","year":"2023","journal-title":"J Yeungnam Med Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.863472","article-title":"Liquid biopsy based circulating biomarkers in metastatic prostate cancer","volume":"12","author":"Dathathri","year":"2022","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i27.6070","article-title":"Application effect of case management nursing based on patient safety in patients with prostate cancer","volume":"12","author":"Zhou","year":"2024","journal-title":"World J Clin cases"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7150\/thno.35131","article-title":"Combination therapy of TGF-\u03b2 Blockade and commensal-derived probiotics provides enhanced antitumor immune response and tumor suppression","volume":"9","author":"Shi","year":"2019","journal-title":"Theranostics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202305724","article-title":"Integration analysis of single-cell multi-omics reveals prostate cancer heterogeneity","volume":"11","author":"Bian","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40164-023-00407-0","article-title":"ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer","volume":"12","author":"Xin","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S441135","article-title":"TME-related biomimetic strategies against cancer","volume":"19","author":"Peng","year":"2024","journal-title":"Int J Nanomed"},{"key":"B14","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.09.039","article-title":"Exosomal long non-coding RNAs: emerging players in the tumor microenvironment","volume":"23","author":"Pathania","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omtn.2022.05.034","article-title":"Exosomal non-coding RNAs have a significant effect on tumor metastasis","volume":"29","author":"Wang","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00744-w","article-title":"Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer","volume":"54","author":"Liu","year":"2022","journal-title":"Exp Mol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1042\/BST20240523","article-title":"Tetraspanins affect membrane structures and the trafficking of molecular partners: what impact on extracellular vesicles","author":"Rubinstein","year":"2025","journal-title":"Biochem Soc Trans"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21274","article-title":"Extracellular vesicles in cardiovascular theranostics","volume":"7","author":"Bei","year":"2017","journal-title":"Theranostics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41419-023-06007-4","article-title":"Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1","volume":"14","author":"Luo","year":"2023","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-025-02170-6","article-title":"Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer","volume":"10","author":"Ma","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12951-025-03326-w","article-title":"Small extracellular vesicles: crucial mediators for prostate cancer","volume":"23","author":"Tang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2021.08.004","article-title":"Exosomes and prostate cancer management","volume":"86","author":"Vlaeminck-Guillem","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1156","article-title":"Exosome-derived circTFDP2 promotes prostate cancer progression by preventing PARP1 from caspase-3-dependent cleavage","volume":"13","author":"Ding","year":"2023","journal-title":"Clin Transl Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s41419-021-04421-0","article-title":"Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p\/FOXM1 axis","volume":"12","author":"Jiang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13008-024-00110-4","article-title":"Exosome-derived lncRNA A1BG-AS1 attenuates the progression of prostate cancer depending on ZC3H13-mediated m6A modification","volume":"19","author":"Yang","year":"2024","journal-title":"Cell Div"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/jca.71706","article-title":"Blood circulating exosomes carrying microRNA-423-5p regulates cell progression in prostate cancer via targeting FRMD3","volume":"13","author":"Wei","year":"2022","journal-title":"J Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3376","article-title":"Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR-1\/MAP 3 K1 axis","volume":"24","author":"Zhang","year":"2022","journal-title":"J Gene Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12038-021-00190-2","article-title":"Exosomal circRNA HIPK3 knockdown inhibited cell proliferation and metastasis in prostate cancer by regulating miR-212\/BMI-1 pathway","volume":"46","author":"Tang","year":"2021","journal-title":"J Biosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-22-0458","article-title":"Exosomal lincROR Promotes Docetaxel Resistance in Prostate Cancer through a \u03b2-catenin\/HIF1\u03b1 Positive Feedback Loop","volume":"21","author":"Jiang","year":"2023","journal-title":"Mol Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"8058770","DOI":"10.1155\/2022\/8058770","article-title":"Exosomal LINC01213 plays a role in the transition of androgen-dependent prostate cancer cells into androgen-independent manners","volume":"2022","author":"Guo","year":"2022","journal-title":"J Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"111398","DOI":"10.1016\/j.cellsig.2024.111398","article-title":"Proangiogenic potential of plasma exosomes from prostate cancer patients","volume":"124","author":"Wang","year":"2024","journal-title":"Cell Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2023.2290769","article-title":"Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance","volume":"21","author":"Zeng","year":"2024","journal-title":"RNA Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.31661\/jbpe.v0i0.2105-1337","article-title":"Bystander effect of therapeutic ultrasound in the presence of cisplatin: an in vitro study on human melanoma cells","volume":"13","author":"Rezaei","year":"2023","journal-title":"J BioMed Phys Eng"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01266-4","article-title":"Bystander effect of antibody-drug conjugates: fact or fiction","volume":"24","author":"Giugliano","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.01.046","article-title":"Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment","volume":"30","author":"Xu","year":"2022","journal-title":"Mol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12935-020-01686-x","article-title":"Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1","volume":"21","author":"Dai","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s10528-022-10251-2","article-title":"Exosomal circKDM4A Induces CUL4B to Promote Prostate Cancer Cell Malignancy in a miR-338-3p-Dependent Manner","volume":"61","author":"Huang","year":"2023","journal-title":"Biochem Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"101299","DOI":"10.1016\/j.bbrep.2022.101299","article-title":"Exosome-mediated transduction of mechanical force regulates prostate cancer migration via microRNA","volume":"31","author":"Liu","year":"2022","journal-title":"Biochem Biophys Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"100211","DOI":"10.1016\/j.esmoop.2021.100211","article-title":"Intratumor morphologic and transcriptomic heterogeneity in (V600E)BRAF-mutated metastatic colorectal adenocarcinomas","volume":"6","author":"Angerilli","year":"2021","journal-title":"ESMO Open"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2118241119","article-title":"Label-free sensing of cells with fluorescence lifetime imaging: The quest for metabolic heterogeneity","volume":"119","author":"Shirshin","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132294","article-title":"Visual intratumor heterogeneity and breast tumor progression","volume":"16","author":"Li","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116339","article-title":"Secreted miR-153 controls proliferation and invasion of higher gleason score prostate cancer","volume":"23","author":"Bertoli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15164148","article-title":"Unraveling the role of EV-derived miR-150-5p in prostate cancer metastasis and its association with high-grade gleason scores: implications for diagnosis","volume":"15","author":"Cruz-Burgos","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s42003-020-01642-5","article-title":"Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer","volume":"4","author":"Albino","year":"2021","journal-title":"Commun Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15948","article-title":"Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-022-00837-6","article-title":"MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4\/STAT3 axis","volume":"54","author":"Gan","year":"2022","journal-title":"Exp Mol Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"117472","DOI":"10.1016\/j.biopha.2024.117472","article-title":"FTH1P8 induces and transmits docetaxel resistance by inhibiting ferroptosis in prostate cancer","volume":"180","author":"Lu","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001365","article-title":"Exosomal circRNA Scm-like with four Malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p\/tribbles homolog 1 pathway","volume":"33","author":"Tan","year":"2022","journal-title":"Anticancer Drugs"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S300376","article-title":"Exosomal circ-XIAP promotes docetaxel resistance in prostate cancer by regulating miR-1182\/TPD52 axis","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2915","article-title":"CircSLC4A7 in resistant-cells-derived exosomes promotes docetaxel resistance via the miR-1205\/MAPT axis in prostate cancer","volume":"76","author":"Lin","year":"2024","journal-title":"IUBMB Life"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S281710","article-title":"Exosomes promote the transition of androgen-dependent prostate cancer cells into androgen-independent manner through up-regulating the heme oxygenase-1","volume":"16","author":"Zhang","year":"2021","journal-title":"Int J Nanomed"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12136","article-title":"Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer","volume":"10","author":"Martens-Uzunova","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.602493","article-title":"The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing","volume":"8","author":"Guo","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12114","article-title":"Prostate cancer small extracellular vesicles participate in androgen-independent transformation of prostate cancer by transferring let-7a-5p","volume":"8","author":"Lei","year":"2022","journal-title":"Heliyon"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2021.01.12","article-title":"Research advances of secretory proteins in Malignant tumors","volume":"33","author":"Zhang","year":"2021","journal-title":"Chin J Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci Transl Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3892\/ijo.2023.5480","article-title":"Interaction of tumor\u2212associated macrophages with stromal and immune components in solid tumors: Research progress (Review)","volume":"62","author":"Kazakova","year":"2023","journal-title":"Int J Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002919","article-title":"Immune cells in the B-cell lymphoma microenvironment: From basic research to clinical applications","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e09033","article-title":"Identification of autophagy related genes in predicting the prognosis and aiding 5- fluorouracil therapy of colorectal cancer","volume":"8","author":"Gao","year":"2022","journal-title":"Heliyon"},{"key":"B61","doi-asserted-by":"publisher","first-page":"215979","DOI":"10.1016\/j.canlet.2022.215979","article-title":"Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment","volume":"552","author":"Chen","year":"2023","journal-title":"Cancer Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1039\/D2NR03053E","article-title":"Spatially targeting and regulating tumor-associated macrophages using a raspberry-like micellar system sensitizes pancreatic cancer chemoimmunotherapy","volume":"14","author":"Li","year":"2022","journal-title":"Nanoscale"},{"key":"B63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/ijo.2022.5471","article-title":"Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)","volume":"62","author":"Naser","year":"2023","journal-title":"Int J Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19428","article-title":"Dissecting pulmonary fibroblasts heterogeneity in lung development, health and diseases","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"B65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12964-023-01204-2","article-title":"Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies","volume":"21","author":"Xu","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1302016","article-title":"Mapping knowledge structure and themes trends of cancer-associated fibroblasts: a text-mining study","volume":"10","author":"Cheng","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03057-6","article-title":"Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer","volume":"43","author":"Zhao","year":"2024","journal-title":"Oncogene"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0431-z","article-title":"Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-\u03b2 signaling pathway","volume":"52","author":"Shan","year":"2020","journal-title":"Exp Mol Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-020-01761-1","article-title":"Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis","volume":"39","author":"Zhang","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30435","article-title":"Fibroblast-derived exosomal microRNA regulates NKX3\u20131 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells","volume":"124","author":"Matsuda","year":"2023","journal-title":"J Cell Biochem"},{"key":"B71","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41417-024-00742-2","article-title":"Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p\/FBXW7\/HSF1 axis under hypoxic microenvironment","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B72","doi-asserted-by":"publisher","first-page":"610","DOI":"10.21037\/atm-22-1715","article-title":"Treatment and application of stem cells from different sources for cartilage injury: a literature review","volume":"10","author":"Wang","year":"2022","journal-title":"Ann Transl Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41420-023-01793-4","article-title":"ZO-1 regulates the migration of mesenchymal stem cells in cooperation with \u03b1-catenin in response to breast tumor cells","volume":"10","author":"Park","year":"2024","journal-title":"Cell Death Discov"},{"key":"B74","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12935-023-02935-5","article-title":"Gastric cancer cell-originated small extracellular vesicle induces metabolic reprogramming of BM-MSCs through ERK-PPAR\u03b3-CPT1A signaling to potentiate lymphatic metastasis","volume":"23","author":"Huang","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9636897231220073","DOI":"10.1177\/09636897231220073","article-title":"The role of mesenchymal stem cells in modulating the breast cancer microenvironment","volume":"32","author":"Zhang","year":"2023","journal-title":"Cell Transplant"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1047907","article-title":"MSCs can be a double-edged sword in tumorigenesis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13577-024-01154-y","article-title":"Mesenchymal stem\/stromal cells: dedicator to maintain tumor homeostasis","volume":"38","author":"Yao","year":"2024","journal-title":"Hum Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15384047.2022.2123675","article-title":"Suppressive function of bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-187 in prostate cancer","volume":"23","author":"Li","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2009416","article-title":"Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p\/IGF1R axis","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"B80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.31083\/j.fbl2709256","article-title":"Targeting castration-resistant prostate cancer using mesenchymal stem cell exosomes for therapeutic microRNA-let-7c delivery","volume":"27","author":"Kurniawati","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"110126","DOI":"10.1016\/j.cellsig.2021.110126","article-title":"Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro","volume":"87","author":"Prigol","year":"2021","journal-title":"Cell Signal"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12587","article-title":"Advances and clinical applications of immune checkpoint inhibitors in hematological Malignancies","volume":"44","author":"Sun","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"101420","DOI":"10.1016\/j.xcrm.2024.101420","article-title":"PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1074477","article-title":"Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.890166","article-title":"Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing","volume":"13","author":"Bai","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.07.021","article-title":"Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer","volume":"25","author":"Kim","year":"2023","journal-title":"Bioact Mater"},{"key":"B88","doi-asserted-by":"publisher","first-page":"122463","DOI":"10.1016\/j.biomaterials.2023.122463","article-title":"Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment","volume":"305","author":"Jin","year":"2024","journal-title":"Biomaterials"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911080","article-title":"Mast cells and dendritic cells as cellular immune checkpoints in immunotherapy of solid tumors","volume":"23","author":"Kalkusova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006581","article-title":"Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment","volume":"11","author":"Xu","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2156091","DOI":"10.1080\/2162402X.2022.2156091","article-title":"Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibition","volume":"12","author":"Koerner","year":"2023","journal-title":"Oncoimmunology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310421","article-title":"Ultrasound imaging of tumor vascular CD93 with MMRN2 modified microbubbles for immune microenvironment prediction","volume":"36","author":"Wang","year":"2024","journal-title":"Adv Mater"},{"key":"B93","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.4103\/jcrt.jcrt_497_22","article-title":"An immunohistochemical evaluation of tumor-associated macrophages (M1 and M2) in carcinoma prostate - An institutional study","volume":"19","author":"Hadimani","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1924396","article-title":"M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer","volume":"53","author":"JiaWei","year":"2021","journal-title":"Ann Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40265-020-01456-z","article-title":"Evolving role of immunotherapy in metastatic castration refractory prostate cancer","volume":"81","author":"Rathi","year":"2021","journal-title":"Drugs"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301943","article-title":"An immune suppressive tumor microenvironment in primary prostate cancer promotes tumor immune escape","volume":"19","author":"Anton","year":"2024","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204115","article-title":"Identification of biomarkers for immunotherapy response in prostate cancer and potential drugs to alleviate immunosuppression","volume":"14","author":"Zhang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.tice.2024.102530","article-title":"Bicalutamide reveals immunomodulatory effects in prostate cancer by regulating immunogenic dendritic cell maturation","volume":"91","author":"Nourbakhsh","year":"2024","journal-title":"Tissue Cell"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133473","article-title":"Lactate as key metabolite in prostate cancer progression: what are the clinical implications","volume":"15","author":"Chetta","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7616696","DOI":"10.1155\/2022\/7616696","article-title":"Exosomal CXCL14 contributes to M2 macrophage polarization through NF-\u03baB signaling in prostate cancer","volume":"2022","author":"Tian","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/genes11121495","article-title":"Extracellular vesicles-mediated transfer of miRNA let-7b from PC3 cells to macrophages","volume":"11","author":"Costanzi","year":"2020","journal-title":"Genes (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05222-1","article-title":"Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression","volume":"480","author":"Guan","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B103","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12967-022-03494-5","article-title":"Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9\/circMID1\/miR-506-3p\/MID1","volume":"20","author":"Gao","year":"2022","journal-title":"J Transl Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29784","article-title":"Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer","volume":"235","author":"Guan","year":"2020","journal-title":"J Cell Physiol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s10020-024-00947-z","article-title":"Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1","volume":"30","author":"Shi","year":"2024","journal-title":"Mol Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04854-5","article-title":"Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression","volume":"479","author":"Zhang","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B107","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/ol.2023.13749","article-title":"Prostate cancer bone metastases biology and clinical management (Review)","volume":"25","author":"Archer Goode","year":"2023","journal-title":"Oncol Lett"},{"key":"B108","doi-asserted-by":"publisher","first-page":"100526","DOI":"10.1016\/j.jbo.2024.100526","article-title":"Role of the osteocyte in bone metastasis - The importance of networking","volume":"44","author":"Verbruggen","year":"2024","journal-title":"J Bone Oncol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B110","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/BCTT.S236168","article-title":"Tumor-draining lymph secretome en route to the regional lymph node in breast cancer metastasis","volume":"12","author":"Mohammed","year":"2020","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10125","article-title":"Tumor cell dormancy and reactivation in bone: skeletal biology and therapeutic opportunities","volume":"3","author":"Byrne","year":"2019","journal-title":"JBMR Plus"},{"key":"B112","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v13.i4.260","article-title":"Calcium channels and their role in regenerative medicine","volume":"13","author":"Ahamad","year":"2021","journal-title":"World J Stem Cells"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4111\/icu.20230026","article-title":"Animal models of bone metastatic prostate cancer","volume":"64","author":"Tae","year":"2023","journal-title":"Investig Clin Urol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"100505","DOI":"10.1016\/j.jbo.2023.100505","article-title":"Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms","volume":"43","author":"Joseph","year":"2023","journal-title":"J Bone Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2016.31.2.206","article-title":"Dissecting tumor-stromal interactions in breast cancer bone metastasis","volume":"31","author":"Kang","year":"2016","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-\u03b2 in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Ju\u00e1rez","year":"2011","journal-title":"Bone"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.493","article-title":"LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p\/runt-related transcription factor 2\/splicing factor proline- and glutamine-rich\/polypyrimidine tract-binding protein 2 axis","volume":"11","author":"Mo","year":"2021","journal-title":"Clin Transl Med"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00563-1","article-title":"Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway","volume":"30","author":"Liu","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B120","doi-asserted-by":"publisher","first-page":"9636897211052977","DOI":"10.1177\/09636897211052977","article-title":"Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2\/RUNX2 cascade","volume":"30","author":"Zou","year":"2021","journal-title":"Cell Transplant"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031285","article-title":"Exosomal miRNAs from prostate cancer impair osteoblast function in mice","volume":"23","author":"Furesi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12056","article-title":"Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p","volume":"10","author":"Yu","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3892\/etm.2021.10739","article-title":"Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K\/AKT\/mTOR pathway","volume":"22","author":"Tian","year":"2021","journal-title":"Exp Ther Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401480R","article-title":"Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT\/mTOR pathway-mediated inhibition of autophagy","volume":"38","author":"Liu","year":"2024","journal-title":"FASEB J"},{"key":"B125","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/aja202351","article-title":"Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS\/miR-214-3p\/CCL5 pathway","volume":"26","author":"Yang","year":"2024","journal-title":"Asian J Androl"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2021.1992853","article-title":"Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment","volume":"20","author":"Li","year":"2021","journal-title":"Cell Cycle"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bulcan.2023.01.008","article-title":"Propofol mediates bone metastasis by regulating PC-derived exosomal miR-142-3p","volume":"110","author":"Chen","year":"2023","journal-title":"Bull Cancer"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S361981","article-title":"Exosome-derived miRNAs as potential biomarkers for prostate bone metastasis","volume":"15","author":"Lu","year":"2022","journal-title":"Int J Gen Med"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11292","article-title":"Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells","volume":"44","author":"Yin","year":"2020","journal-title":"Cell Biol Int"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.30","article-title":"MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells","volume":"1","author":"Ninio-Many","year":"2014","journal-title":"Oncoscience"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2018.07.003","article-title":"MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance","volume":"70","author":"Iqbal","year":"2018","journal-title":"Mol Aspects Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13046-022-02406-1","article-title":"Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention","volume":"41","author":"Mirzaei","year":"2022","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14500","article-title":"The regulatory role and clinical application prospects of circRNA in the occurrence and development of CNS tumors","volume":"30","author":"Zhang","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12964-023-01102-7","article-title":"Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment","volume":"21","author":"Jahromi","year":"2023","journal-title":"Cell Commun Signaling: CCS"},{"key":"B135","doi-asserted-by":"publisher","first-page":"116409","DOI":"10.1016\/j.biopha.2024.116409","article-title":"Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma","volume":"173","author":"Huang","year":"2024","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.685344","article-title":"Circulating extracellular vesicles carry immune regulatory miRNAs and regulate vaccine efficacy and local inflammatory response after vaccination","volume":"12","author":"Oshiumi","year":"2021","journal-title":"Front In Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3383","article-title":"Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review)","volume":"41","author":"Pan","year":"2018","journal-title":"Int J Mol Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers12010017","article-title":"Liquid biopsy in non-small cell lung cancer: highlights and challenges","volume":"12","author":"Rijavec","year":"2019","journal-title":"Cancers"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-023-01406-9","article-title":"Liquid biopsy in low-grade glioma: A systematic review and a proposal for a clinical utility score","volume":"43","author":"Zanin","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"9702562","DOI":"10.1155\/2019\/9702562","article-title":"An update on novel therapeutic warfronts of extracellular vesicles (EVs) in cancer treatment: where we are standing right now and where to go in the future","volume":"2019","author":"Khawar","year":"2019","journal-title":"Oxid Med Cell Longevity"},{"key":"B141","doi-asserted-by":"publisher","first-page":"102979","DOI":"10.1016\/j.ctrv.2025.102979","article-title":"Advancements in liquid biopsy for breast Cancer: Molecular biomarkers and clinical applications","volume":"139","author":"Qiu","year":"2025","journal-title":"Cancer Treat Rev"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1644861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:30:15Z","timestamp":1763706615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1644861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":141,"alternative-id":["10.3389\/fimmu.2025.1644861"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1644861","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1644861"}}